Development of a predictive model for recurrence in postoperative glottic laryngeal squamous cell carcinoma patients following adjuvant chemotherapy based on PNI, NLR, and PLR

The Nomogram model developed in this study integrates multiple clinical and inflammatory-immune indicators, enabling accurate prediction of 12-, 24-, and 36-month recurrence-free survival rates in post-surgical patients with glottic laryngeal cancer. The model holds significant clinical value, with IL-6, IL-8, and PNI identified as crucial indicators for predicting recurrence risk, providing valuable insights for postoperative follow-up and individualized treatment strategies.